BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18272203)

  • 1. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians.
    den Reijer PM; Maier AB; Westendorp RG; van Heemst D
    Mech Ageing Dev; 2008 Apr; 129(4):175-82. PubMed ID: 18272203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
    Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
    Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between TP53 codon 72 single-nucleotide polymorphism and radiation sensitivity of human fibroblasts.
    Alsbeih G; Al-Harbi N; Al-Buhairi M; Al-Hadyan K; Al-Hamed M
    Radiat Res; 2007 May; 167(5):535-40. PubMed ID: 17474797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
    Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
    Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.
    Testa R; Bonfigli AR; Salvioli S; Invidia L; Pierini M; Sirolla C; Marra M; Testa I; Fazioli F; Recchioni R; Marcheselli F; Olivieri F; Lanari L; Franceschi C
    Mech Ageing Dev; 2009 Aug; 130(8):497-500. PubMed ID: 19523975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced responses of human skin fibroblasts in vitro reflect human longevity.
    Dekker P; Maier AB; van Heemst D; de Koning-Treurniet C; Blom J; Dirks RW; Tanke HJ; Westendorp RG
    Aging Cell; 2009 Sep; 8(5):595-603. PubMed ID: 19681808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis.
    Kuroda Y; Nakao H; Ikemura K; Katoh T
    Oral Oncol; 2007 Nov; 43(10):1043-8. PubMed ID: 17306604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72].
    Liu Y; Gao J; Liu X; Lu F; Liu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Dec; 22(12):1433-6. PubMed ID: 19137883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
    Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY
    Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer.
    Kyndi M; Alsner J; Hansen LL; Sørensen FB; Overgaard J
    Acta Oncol; 2006; 45(5):602-9. PubMed ID: 16864176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer.
    Santos AM; Sousa H; Pinto D; Portela C; Pereira D; Catarino R; Duarte I; Lopes C; Medeiros R
    Eur J Cancer; 2006 May; 42(7):958-63. PubMed ID: 16542834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts.
    Chen W; Kang J; Xia J; Li Y; Yang B; Chen B; Sun W; Song X; Xiang W; Wang X; Wang F; Wan Y; Bi Z
    Int J Mol Med; 2008 May; 21(5):645-53. PubMed ID: 18425358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
    Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
    Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.